Below you can find consensus from equity research analysts that currently cover Fluidra's stock (updated on a monthly basis).
FY 2024 (in €M):
| Metric | Min | Max | Average | Contr. |
|---|---|---|---|---|
| Sales | 2,007 | 2,126 | 2,067 | 19 |
| Adjusted EBITDA | 441 | 477 | 462 | 17 |
| Adjusted EBITA | 361 | 392 | 374 | 9 |
| Cash Net Profit | 206 | 235 | 221 | 9 |
| Cash EPS | 1,07 | 1,22 | 1,15 | 11 |
| Net Working Capital | 366 | 497 | 394 | 15 |
| Net Debt | 1,044 | 1,169 | 1,104 | 17 |
FY 2025 (in €M):
| Metric | Min | Max | Average | Contr. |
|---|---|---|---|---|
| Sales | 2,087 | 2,230 | 2,178 | 19 |
| Adjusted EBITDA | 477 | 523 | 507 | 17 |
| Adjusted EBITA | 400 | 432 | 420 | 8 |
| Cash Net Profit | 232 | 271 | 255 | 8 |
| Cash EPS | 1,21 | 1,41 | 1,34 | 9 |
| Net Working Capital | 384 | 527 | 415 | 15 |
| Net Debt | 911 | 1,129 | 990 | 16 |
* Data as of 22.07.2024
Notes:
- A total of 19 analysts cover Fluidra. The consensus presented above includes figures from those analysts who have published updated estimates over the last 6 months (19 analysts).
- The metrics compiled above are consistent with Fluidra's reporting metrics. Fluidra does not alter the figures in any way.